PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Buenos Aires, Argentina.\', \'Servicio de Electrofisiología Cardíaca, Arritmias y Marcapasos, Sanatorio Otamendi y Miroli, Buenos Aires, Argentina.\', \'Hospital de Clínicas \'José de San Martín\', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.\', \'Segunda Cátedra de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.\', \'Department of Pathology, Hospital de Alta Complejidad El Calafate SAMIC, Santa Cruz, Argentina.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/ddr.21679
?:doi
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 32356926
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32356926>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32356926>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all